Gibson, C. M. Et Al. 2017. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy. JOURNAL OF THE AMERICAN HEART ASSOCIATION , vol.6, no.7 .

Gibson, C. M., Korjian, S., Chi, G., Daaboul, Y., Jain, P., Arbetter, D., ... Goldhaber, S. Z.(2017). Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy. JOURNAL OF THE AMERICAN HEART ASSOCIATION , vol.6, no.7.

Gibson, C. Et Al. "Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy," JOURNAL OF THE AMERICAN HEART ASSOCIATION , vol.6, no.7, 2017

Gibson, C. M. Et Al. "Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy." JOURNAL OF THE AMERICAN HEART ASSOCIATION , vol.6, no.7, 2017

Gibson, C. M. Et Al. (2017) . "Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy." JOURNAL OF THE AMERICAN HEART ASSOCIATION , vol.6, no.7.

@article{article, author={C. Michael Gibson Et Al. }, title={Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy}, journal={JOURNAL OF THE AMERICAN HEART ASSOCIATION}, year=2017}